Differential effects of the neuroprotectant lubeluzole on bovine and mouse chromaffin cell calcium channel subtypes

British Journal of Pharmacology

Volumn 122, Issue 2, 1997, Pages 275-285

  Hernández Guijo, Jesús M ^b   Gandía, Luis ^b   De Pascual, Ricardo ^b   García, Antonio G ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b NONE

Author keywords

Calcium channel; Chromaffin cell; Lubeluzole; R91154

Indexed keywords

AMINO ACID RECEPTOR AFFECTING AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; LUBELUZOLE; NIFEDIPINE; OMEGA CONOTOXIN MVIIC;

ANIMAL CELL; ARTICLE; CATTLE; CHROMAFFIN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VOLTAGE CLAMP;

ANIMALS; BARIUM; CALCIUM CHANNEL BLOCKERS; CATTLE; CHROMAFFIN CELLS; MICE; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; PIPERIDINES; STEREOISOMERISM; THIAZOLES;

EID: 0030777379     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701364     Document Type: Article

References (28)

1. ALBILLOS, A., GARCIA, A.G. & GANDIA, L. (1993). ω-Agatoxin-IVA-sensitive calcium channels in bovine chromaffin cells. FEBS Lett., 336, 259-262.
2. 2+ concentrations. Pflügers Arch. Eur. J. Physiol., 432, 1030-1038.
3. + -channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other neuroprotective drugs. Brain Res., 745, 210-221.
4. BUCHKREMER-RATZMANN, I. & WITTE, O.W. (1995). Periinfarct and transhemispheric diaschisis caused by photothrombotic infarction in rat neocortex is reduced by lubeluzole but not MK-801. J. Cereb. Blood Flow Metab., 15, (Suppl. I), S381.
5. CHOI, D.W. (1995). Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci., 18, 58-60.
6. DE RYCK, M. (1997). Protection of neurological function in stroke models and neuroprotective properties of lubeluzole. Cerebrovasc. Dis., 7, (Suppl. 2), 18-30.
7. DE RYCK, M., KEERSMAEKERS, R., DUYTSCHAEVER, H., CLAES, C., CLINCKE, G., JANSSEN, M. & VAN REET, G. (1996). Lubeluzole protects sensorimotor function and reduces infarct size in a photochemical stroke model in rats. J. Pharmacol. Exp. Ther., 279, 748-758.
8. DIENER, H.C., HACKE, W., HENNERICI, M., RADBERG, J., HANTSON, L. & DE KEYSER, J. (1996). Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Stroke, 27, 76-81.
9. FENWICK, E.M., MARTY, A. & NEHER, E. (1982). Sodium and calcium currents in bovine chromaffin cells. J. Physiol., 331, 599-635.
10. GANDIA, L., ALBILLOS, A. & GARCIA, A.G. (1993). Bovine chromaffin cells possess FTX-sensitive calcium channels. Biochem. Biophys. Res. Commun., 194, 671-676.
11. GARCEZ-DO CARMO, L., ALBILLOS, A., ARTALEJO, A.R., DE LA FUENTE, M.T., LOPEZ, M.G., GANDIA, L., MICHELENA, P. & GARCIA, A.G. (1993). R56865 inhibits catecholamine from bovine chromaffin cells by blocking calcium channels. Br. J. Pharmacol., 110, 1149-1155.
12. GARCIA, A.G., ALBILLOS, A., GANDIA, L., LOPEZ, M.G., MICHELENA, P. & MONTIEL, C. (1997). ω-Toxins, calcium channels and neurosecretion. In Cellular and Molecular Mechanisms of Toxin Action. Toxins and Signal Transduction, ed. Lazarovici, P. & Gutman, Y. pp. 155-209. Amsterdam: Harwood Academic Publishers.
13. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free patches. Pflügers Arch. Eur. J. Physiol., 391, 85-100.
14. LESAGE, A.S., PEETERS, L. & LEYSEN, J.E. (1996). Lubeluzole, a novel long-term neuroprotectant, inhibits the glutamate-activated nitric oxide synthase pathway. J. Pharmacol. Exp. Ther., 279, 759-766.
15. LIVET, B.G. (1984). Adrenal medullary chromaffin cells in vitro. Physiol. Rev., 64, 1103-1161.
16. 2+ signals and secretion in chromaffin cell subtypes. Am. J. Physiol., 272, C476-C484.
17. LOPEZ, M.G., ARTALEJO, A.R., GARCIA, A.G., NEHER, E. & GARCIA-SANCHO, J. (1995). Veratridine-induced oscillations of cytosolic calcium and membrane potential in bovine chromaffin cells. J. Physiol., 482, 15-27.
18. 2+ channels dominate the control of secretion in bovine chromaffin cells. FEBS Lett., 349, 331-337.
19. MAIESE, K., TENBROEKE, K. & KUE, I. (1997). Neuroprotection of lubeluzole is mediated through the signal transduction pathway of nitric oxide. J. Neurochem., 68, 710-714.
20. 2+ oscillations induced by veratridine. Eur. J. Pharmacol., 270, 331-339.
21. 2+ oscillations. Brain Res., 714, 209-214.
22. MORO, M.A., LOPEZ, M.G., GANDIA, L., MICHELENA, P. & GARCIA, A.G. (1990). Separation of living adrenaline-and noradrenaline-containing cells from bovine adrenal medullae. Anal. Biochem., 185, 243-248.
23. OLIVERA, B.M., MILJANICH, G., RAMACHANDRAN, J. & ADAMS, M.E. (1994). Calcium channel diversity and neurotransmitter release: the ω-conotoxins and ω-agatoxins. Annu. Rev. Biochem., 63, 823-867.
24. PAUWELS, P.J., PEETERS, L., VAN ASOUW, H.P. & LEYSEN, J.E. (1991). Neuroprotective profile of R83088, R84418, and R84419 using rat hippocampal neuronal cultures. Janssen Preclinical Research Report, R8444198.
25. SCHELLER, D., KOLB, J., SZATHMARY, S., ZACHARIAS, E., DE RYCK, M., VAN REEMPTS, J., CLINKE, B. & TEGTMEIER, F. (1995). Extracellular changes of glutamate in the periinfarct zone. Effect of lubeluzole. J. Cereb. Blood Flow Metab., 15, (Suppl. I) S379.
26. TAKAHASHI, T. & MOMIYAMA, A. (1993). Different types of calcium channels mediate central synaptic transmission. Nature, 366, 156-158.
27. TURNER, T.J., ADAMS, M.E. & DUNLAP, K. (1992). Calcium channels coupled to glutamate release identified by ω-aga-IVA. Science, 258, 310-313.
28. VILLARROYA, M., GANDIA, L., LARA, B., ALBILLOS, A., LOPEZ, M.G. & GARCIA, A.G. (1995). Dotarizine versus flunarizine as calcium antagonists in chromaffin cells. Br. J. Pharmacol., 114, 369-376.